The DOI matches its Crossref record; 1,858 of the 1,862 references it cites were found in a registry or an index.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Open accessAbstract
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








![Fig. 9 Antiproteolytic effect of acetaldehyde in the single pass perfused rat liver. a Acetaldehyde (5 mmol/l) was infused into the perfused liver for 30 min, and the release of [3H]leucine from pre-labeled rats was taken as a measure of proteolysis. b The resulting inhibition of proteolysis under steady-state conditions at different concentrations of acetaldehyde. Data are from 2 to 4 different experiments and are given as mean ± SEM. From vom Dahl and Häussinger (1998)](/paper-figures/2844bb4a493e46429af445399835e22f/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes-figure-9.jpg)
















































Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Already in the first few days of cultivation, a reduction of hepatic functions can be observed, e.g. production of plasma proteins, drug metabolizing enzyme activities, glucose metabolism and urea synthesis (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although cytotoxicity measures are fundamental in the assessment of a drug’s potential for hepatotoxicity in vitro33,34, gene expression and various phenotypic changes can occur at much lower concentrations35,36.”
From Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology (2022) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The apical membrane is equipped with transport proteins that eliminate bile acids and xenobiotics from the cell, like multidrug resistance-associated protein 2 (MRP2) (Godoy et al., 2013[15]; Ito et al., 2005[20]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The hepatocyte's basal membrane faces the sinusoid. It expresses several transmembrane transporters that manage the exchange of substances with the sinusoidal blood stream (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“In vivo, the distribution of ECM components varies between the different parts of the liver acinus, the smallest organizational unit of the liver (Godoy et al., 2013[15]; Martinez-Hernandez and Amenta, 1993[26]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In practice, strategies for optimizing HepG2 can be divided into several approaches. The first approach is based on genetic modification of cells to express key biotransformation enzymes, in particular cytochrome P450 isoforms [109]. The second approach involves epigenetic and cultural maturation of cells, which allows for increased expression of nuclear receptors and, consequently, of xenobiotic”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [163]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Wheat proteins improve cryopreservation of rat hepatocytes
Grondin, M., Hamel, F., Averill‐Bates, D. A., & Sarhan, F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22270 · Cited by 18
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Computer Simulation of Liquids
Allen, M. P., & Tildesley, D. J. (2017) · doi:10.1093/oso/9780198803195.001.0001 · Cited by 20,945
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Computer Simulation of Liquids
P, S., & J, K. (1988) · Journal of Molecular Liquids · doi:10.1016/0167-7322(88)80022-9 · Cited by 16,088
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
Research works printed but not linked: 9
- Bode JG (2011) Inflammation and liver regeneration. In: Häussinger D (ed) Liver regneration. DeGruyter Verlag, Berlin
- Bücher T, Sies H (1976) Mitochondrial and cytosolic redox states in perfused rat liver: methods and problems in metabolic compartmentation. In: Tager jm WJ, Söling D (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publishing Company/American Elsevier, New York/Amsterdam
- EPA (2012) EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS Comments. Environmental Protection Agency (EPA), Washington, DC
- Hallifax D, Foster JA, Houston JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150–2161 · DOI
- ITC (International Transporter Consortium) (2010) Membrane transporters in drug development (Report from the FDA Critical Path Workshop). Nat Rev Drug Discov 9:215–236 · DOI · Paper page
- Lamers W, Moorman A, Charles R (1989) The metabolic lobulus, a key to the architecture of the liver. In: Revisiones Sobre Biologia Celular, Springer, New York
- Sahin S (2003) Perfused liver preparation and its applications. FABAD J Pharm Sci 28:39–49
- Waddington CH (1942) The epigenotype. Endeavour 1:18–20
- Warburg O (1923) Versuche an überlebendem Karzinomgewebe. Biochem Z 142:317
Cited by
Sorted by citations
Items 201–300 of 1,002
Expansion of functional personalized cells with specific transgene combinations
Lipps, C., Klein, F., Wahlicht, T., Seiffert, V., Butueva, M., Zauers, J., Truschel, T., Luckner, M., Köster, M., MacLeod, R. A. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03408-4 · Cited by 63
Advances in Engineered Human Liver Platforms for Drug Metabolism Studies
Underhill, G. H., & Khetani, S. R. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083295 · Cited by 64
Gröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21868 · Cited by 60
Insulin resistance in the liver: Deficiency or excess of insulin?
Bazotte, R. B., Silva, L. G., & Schiavon, F. P. M. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947750 · Cited by 64
Physiological oxygen tension reduces hepatocyte dedifferentiation in in vitro culture
Guo, R., Xu, X., Lu, Y., & Xie, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-06433-3 · Cited by 61
Kvist, A. J., Kanebratt, K. P., Walentinsson, A., Palmgren, H., O’Hara, M., Björkbom, A., Andersson, L. C., Ahlqvist, M. M., & Andersson, T. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.026 · Cited by 61
Bernasconi, C., Pelkonen, O., Andersson, T. B., Strickland, J. A., Wilk–Zasadna, I., Asturiol, D., Cole, T., Liška, R., Worth, A. P., Müller‐Vieira, U., et al. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.05.019 · Cited by 60
Self-contained, low-cost Body-on-a-Chip systems for drug development
Wang, Y. I., Oleaga, C., Long, C. J., Esch, M. B., McAleer, C. W., Miller, P. G., Hickman, J. J., & Shuler, M. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694101 · Cited by 59
Atienzar, F., Blomme, E. A. G., Chen, M., Hewitt, P. G., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter‐Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 60
Self-citation3D Cultivation Techniques for Primary Human Hepatocytes
Bachmann, A., Moll, M., Gottwald, E., Nies, C., Zantl, R., Wagner, H., Burkhardt, B., Sánchez, J., Ladurner, R., Thasler, W., et al. (2015) · Microarrays · doi:10.3390/microarrays4010064 · Cited by 59
Self-citationPregnane X receptor and drug-induced liver injury
Wang, Y., Chai, S. C., Brewer, C., & Chen, T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.963555 · Cited by 59
Sutherland, J. J., Jolly, R. A., Goldstein, K. M., & Stevens, J. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004847 · Cited by 60
Silva, B., Fernandes, C., Tiritan, M. E., Pinto, M. M. M., Valente, M. J., Carvalho, M. C., de Pinho, P. G., & Remião, F. (2016) · Forensic Toxicology · doi:10.1007/s11419-016-0324-y · Cited by 59
Grant, R., Hay, D. C., & Callanan, A. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0419 · Cited by 60
Deharde, D., Schneider, C., Hiller, T., Fischer, N., Kegel, V., Lübberstedt, M., Freyer, N., Hengstler, J. G., Andersson, T. B., Seehofer, D., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1758-z · Cited by 58
Self-citationWang, J., Wang, J., Xu, C., Liu, R., & Chen, Y. (2016) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.11.060 · Cited by 58
Microfluidic platforms for modeling biological barriers in the circulatory system
Yu, F., Kumar, N. D. O. S., Choudhury, D., Foo, L. C., & Ng, S. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.036 · Cited by 60
Hepatotoxicity of perfluorooctanoic acid and two emerging alternatives based on a 3D spheroid model
Sun, S., Guo, H., Wang, J., & Dai, J. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2018.12.065 · Cited by 60
Rivera, K. R., Yokus, M. A., Erb, P. D., Pozdin, V. A., & Daniele, M. (2019) · The Analyst · doi:10.1039/c8an02201a · Cited by 57
Liver Tissue Engineering as an Emerging Alternative for Liver Disease Treatment
Mirdamadi, E. S., Kalhori, D., Zakeri, N., Azarpira, N., & Solati-Hashjin, M. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0233 · Cited by 57
Cox, C. R., Lynch, S., Goldring, C. E., & Sharma, P. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.611913 · Cited by 58
Self-citationGianmoena, K., Gasparoni, N., Jashari, A., Gabrys, P., Grgas, K., Ghallab, A., Nordström, K. J. V., Gasparoni, G., Reinders, J., Edlund, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109526 · Cited by 57
Self-citationGómez-Lechón, M. J., & Tolosa, L. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1756-1 · Cited by 57
Self-citationCampos, G., Schmidt‐Heck, W., Ghallab, A., Rochlitz, K., Pütter, L., Medinas, D. B., Hetz, C. A., Widera, A., Cadenas, C., Begher‐Tibbe, B., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1240-8 · Cited by 56
Self-citationMechanisms and in vitro models of drug-induced cholestasis
Gijbels, E., Vilas‐Boas, V., Deferm, N., Devisscher, L., Jaeschke, H., Annaert, P., & Vinken, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02437-2 · Cited by 59
Self-citationWang, Z., Luo, X., Anene-Nzelu, C. G., Yu, Y., Hong, X., Singh, N. H., Xia, L., Liu, S., & Yu, H. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3090 · Cited by 56
Kuijk, E., Rasmussen, S. A., Blokzijl, F., Huch, M., Gehart, H., Toonen, P. W., Begthel, H., Clevers, H. C., Geurts, A. M., & Cuppen, E. P. J. G. (2016) · Scientific Reports · doi:10.1038/srep22154 · Cited by 57
Liver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 56
An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D
Ott, L. M., Ramachandran, K., & Stehno‐Bittel, L. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217701058 · Cited by 57
Sezgin, S., Hassan, R. A. R. A., Zühlke, S., Kuepfer, L., Hengstler, J. G., Spiteller, M., & Ghallab, A. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2271-3 · Cited by 56
Self-citationCui, J., Wang, H., Zheng, Z., Shi, Q., Sun, T., Huang, Q., & Fukuda, T. (2018) · Biofabrication · doi:10.1088/1758-5090/aaf3c9 · Cited by 57
Wagmann, L., Frankenfeld, F., Park, Y. M., Herrmann, J. E., Fischmann, S., Westphal, F., Müller, R., Flockerzi, V., & Meyer, M. R. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00539 · Cited by 55
Luce, E., Messina, A., Duclos‐Vallée, J., & Dubart‐Kupperschmitt, A. (2021) · Hepatology · doi:10.1002/hep.31705 · Cited by 56
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 56
Self-citationCell Culture Models for Hepatitis E Virus
Fu, R., Decker, C. C., & Thi, V. L. D. (2019) · Viruses · doi:10.3390/v11070608 · Cited by 54
In vitro characterization of hepatic toxicity of Alternaria toxins
Hessel‐Pras, S., Kieshauer, J., Roenn, G., Luckert, C., Braeuning, A., & Lampen, A. (2018) · Mycotoxin Research · doi:10.1007/s12550-018-0339-9 · Cited by 53
Self-citationBerg, E. L., Hsu, Y.-C., & Lee, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.013 · Cited by 57
Hansjosten, I., Rapp, J., Reiner, L., Vatter, R., Fritsch‐Decker, S., Peravali, R., Palosaari, T., Joossens, E., Gerloff, K., Macko, P., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2106-7 · Cited by 53
Modelling the metastatic cascade by in vitro microfluidic platforms
Samatov, T. R., Shkurnikov, M. Y., Tonevitskaya, S. A., & Tonevitsky, A. (2015) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2015.01.001 · Cited by 53
Richter, L. H. J., Herrmann, J. E., Andreas, A., Park, Y. M., Wagmann, L., Flockerzi, V., Müller, R., & Meyer, M. R. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.01.010 · Cited by 56
Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
Mosedale, M., & Watkins, P. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01297 · Cited by 53
Zonation of Nitrogen and Glucose Metabolism Gene Expression upon Acute Liver Damage in Mouse
Ghafoory, S., Breitkopf‐Heinlein, K., Li, Q., Scholl, C., Dooley, S., & Wölfl, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078262 · Cited by 52
Self-citationJärvinen, E., Hammer, H., Poetz, O., Ingelman‐Sundberg, M., & Stage, T. B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2887 · Cited by 53
Reaction phenotyping to assess victim drug-drug interaction risks
Di, L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1367280 · Cited by 51
Ortega‐Ribera, M., Fernández‐Iglesias, A., Illa, X., Moya, A., Molina, V., Maeso‐Díaz, R., Fondevila, C., Peralta, C., Bosch, J., Villa, R., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26776 · Cited by 51
Järvinen, P. P., Bonabi, A., Jokinen, V. P., & Sikanen, T. M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000479 · Cited by 52
Sk, M. M., Das, P., Panwar, A., & Tan, L. P. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111694 · Cited by 51
Fanizza, F., Campanile, M., Forloni, G., Giordano, C., & Albani, D. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221095339 · Cited by 55
Characterization of hepatocyte-based in vitro systems for reliable toxicity testing
Vinken, M., & Hengstler, J. G. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2297-6 · Cited by 57
Self-citationIn Vitro Models for Studying Chronic Drug-Induced Liver Injury
Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 52
Self-citationHagenbuch, B., Stieger, B., & Locher, K. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100023 · Cited by 49
Self-citationBile canalicular dynamics in hepatocyte sandwich cultures
Reif, R., Karlsson, J., Günther, G., Beattie, L., Wrangborg, D., Hammad, S., Begher‐Tibbe, B., Damle‐Vartak, A., Melega, S., Kaye, P. M., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1575-9 · Cited by 50
Self-citationKegel, V., Pfeiffer, E., Burkhardt, B., Liu, J. L., Zeilinger, K., Nussler, A. K., Seehofer, D., & Damm, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/640631 · Cited by 51
Self-citationEvolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy
Vernetti, L. A., Vogt, A., Gough, A., & Taylor, D. L. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.013 · Cited by 50
Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes
Gu, X., Albrecht, W., Edlund, K., Kappenberg, F., Rahnenführer, J., Leist, M., Moritz, W., Godoy, P., Cadenas, C., Marchan, R., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2302-0 · Cited by 54
Self-citationElblehi, S. S., Hafez, M., & El-Sayed, Y. S. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-04395-9 · Cited by 50
Kermanizadeh, A., Powell, L. G., & Stone, V. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1751756 · Cited by 50
Allard, C., Schué, L., Fossard, F., Recher, G., do Nascimento, R. O., Emmanuel Flahaut, B., Loiseau, A., Desjardins, P., Martel, R., & Gaufrès, É. (2020) · Advanced Materials · doi:10.1002/adma.202001429 · Cited by 54
Human liver model systems in a dish
Thompson, W. L., & Takebe, T. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12708 · Cited by 54
Fullerene C60 nanoparticles ameliorated cyclophosphamide-induced acute hepatotoxicity in rats
Elshater, A.-E. A., Haridy, M., Salman, M. M. A., Fayyad, A. S., & Hammad, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.134 · Cited by 49
Self-citationBioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies
Bouwmeester, M., Bernal, P. N., Oosterhoff, L. A., van Wolferen, M. E., Lehmann, V., Vermaas, M., Buchholz, M., Peiffer, Q. C., Malda, J., van der Laan, L. J. W., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100327 · Cited by 51
Kumari, J., Karande, A. A., & Kumar, A. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b08607 · Cited by 48
Engineered Livers for Infectious Diseases
Gural, N., Mâncio-Silva, L., He, J., & Bhatia, S. N. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.005 · Cited by 52
The liver as an immunological barrier redefined by single‐cell analysis
Stamataki, Z., & Swadling, L. (2020) · Immunology · doi:10.1111/imm.13193 · Cited by 48
Kiamehr, M., Heiskanen, L., Laufer, T., Düsterloh, A., Kahraman, M., Käkelä, R., Laaksonen, R., & Aalto‐Setälä, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122910 · Cited by 47
Huo, X., Meng, X., Zhang, J., & Zhao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109354 · Cited by 47
Cell‐type‐resolved proteomic analysis of the human liver
Ölander, M., Wiśniewski, J. R., & Artursson, P. (2020) · Liver International · doi:10.1111/liv.14452 · Cited by 47
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
Pinheiro, D., Dias, I., Ribeiro Silva, K., Stumbo, A. C., Thole, A., Cortez, E., de Carvalho, L., Weiskirchen, R., & Carvalho, S. (2019) · Cells · doi:10.3390/cells8111339 · Cited by 46
Khairnar, R., Islam, M. A., Fleishman, J. S., & Kumar, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121185 · Cited by 49
van Wenum, M., Chamuleau, R. A. F. M., van Gulik, T. M., Siliakus, A. R., Seppen, J., & Hoekstra, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.950651 · Cited by 46
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
Bale, S. S., Moore, L., Yarmush, M. L., & Jindal, R. (2016) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2016.0031 · Cited by 47
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 49
Hariparsad, N., Ramsden, D., Palamanda, J. R., DeKeyser, J. G., Fahmi, O. A., Kenny, J. R., Einolf, H. J., Mohutsky, M. A., Pardon, M., Siu, Y. A., et al. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074567 · Cited by 46
Animal models of portal hypertension
Königshofer, P., Brusilovskaya, K., Schwabl, P., & Reiberger, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.018 · Cited by 46
A review on genotoxicity in connection to infertility and cancer
Choudhuri, S., Kaur, T., Jain, S., Sharma, C., & Asthana, S. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109531 · Cited by 46
Constructing biomimetic liver models through biomaterials and vasculature engineering
Lv, W., Zhou, H., Aazmi, A., Yu, M., Xu, X., Yang, H., Huang, Y. Y. S., & Ma, L. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac079 · Cited by 45
Yuan, J., Li, W., Huang, J., Guo, X., Li, X., Lü, X., Huang, X., & Zhang, H. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0208-9 · Cited by 45
Liver-Regenerative Transplantation: Regrow and Reset
de l’Hortet, A. C., Takeishi, K., Guzman‐Lepe, J., Handa, K., Matsubara, K., Fukumitsu, K., Dorko, K., Presnell, S. C., Yagi, H., & Soto–Gutiérrez, A. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13678 · Cited by 45
Granitzny, A., Knebel, J., Müller, M., Braun, A. C., Steinberg, P., Dasenbrock, C., & Hansen, T. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.02.001 · Cited by 48
Cell Microarray Technologies for High-Throughput Cell-Based Biosensors
Hong, H. J., Koom, W. S., & Koh, W. (2017) · Sensors · doi:10.3390/s17061293 · Cited by 45
Road Map for Development of Stem Cell-Based Alternative Test Methods
Sachinidis, A., Albrecht, W., Nell, P., Cherianidou, A., Hewitt, N. J., Edlund, K., & Hengstler, J. G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.003 · Cited by 45
Self-citationDas, P., DiVito, M. D., Wertheim, J. A., & Tan, L. P. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110723 · Cited by 46
Crosstalk Between the Hepatic and Hematopoietic Systems During Embryonic Development
Soares‐da‐Silva, F., Peixoto, M. M., Cumano, A., & Pinto‐do‐Ó, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00612 · Cited by 45
Kasturi, M., Mathur, V., Gadre, M. A., Srinivasan, V., & Vasanthan, K. S. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00576-3 · Cited by 44
Tanner, N., Kubik, L., Luckert, C., Thomas, M., Hofmann, U., Zanger, U. M., Böhmert, L., Lampen, A., & Braeuning, A. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078675 · Cited by 44
Self-citationDevelopment of organoid-based drug metabolism model
Park, E., Kim, H. K., Jee, J., Hahn, S., Jeong, S., & Yoo, J. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114790 · Cited by 44
Drug–Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization
Gan, J., Zhang, H., & Humphreys, W. G. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00274 · Cited by 44
The application of engineered liver tissues for novel drug discovery
Lin, C., Ballinger, K. R., & Khetani, S. R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032241 · Cited by 45
Cipriano, M., Freyer, N., Knöspel, F., Oliveira, N., Bárcia, R. N., Cruz, P. E., Cruz, H., Castro, M., Santos, J. M., Zeilinger, K., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1838-0 · Cited by 44
Ruoß, M., Häussling, V., Schügner, F., Damink, L. H. H. O., Lee, S. M. L., Ge, L., Ehnert, S., & Nussler, A. K. (2018) · Bioengineering · doi:10.3390/bioengineering5040086 · Cited by 44
Self-citationCharacterisation of a functional rat hepatocyte spheroid model
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Harding, A. L., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.014 · Cited by 43
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
Tasnim, F., Toh, Y., Qu, Y., Li, H., Phan, D., Narmada, B. C., Ananthanarayanan, A., Mittal, N., Meng, R. Q., & Yu, H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00119 · Cited by 42
Cipriano, M., Correia, J. C., Camões, S. P., Oliveira, N., Cruz, P. E., Cruz, H., Castro, M., Ruas, J. L., Santos, J. M., & Miranda, J. P. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1901-x · Cited by 44
Yamasaki, C., Ishida, Y., Yanagi, A., Yoshizane, Y., Kojima, Y., Ogawa, Y., Kageyama, Y., Iwasaki, Y., Ishida, S., Chayama, K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237809 · Cited by 42
Hepatotoxicity due to herbal dietary supplements: Past, present and the future
Gurley, B. J., McGill, M. R., & Koturbash, I. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113445 · Cited by 43
In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment
Llewellyn, S. V., Niemeijer, M., Nymark, P., Moné, M. J., van de Water, B., Conway, G. E., Jenkins, G. J. S., & Doak, S. H. (2021) · Small · doi:10.1002/smll.202006055 · Cited by 41
Detecting reactive drug metabolites for reducing the potential for drug toxicity
Grillo, M. P. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1048222 · Cited by 41
MicroRNA-122: A Novel Hepatocyte-Enriched in vitro Marker of Drug-Induced Cellular Toxicity
Kia, R., Kelly, L., Sison-Young, R. L. C., Zhang, F., Pridgeon, C. S., Heslop, J. A., Metcalfe, P., Kitteringham, N. R., Baxter, M. A., Harrison, S. P., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu269 · Cited by 41
Self-citationWeaver, R. J., Betts, C. J., Blomme, E. A. G., Gerets, H. H. J., Jensen, K. G., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 41
Self-citation
Metadata
- Authors
- Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez-Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nussler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., & Hengstler, J. G.
- Affiliations
- University of Zurich (CH)
- Leibniz Research Centre for Working Environment and Human Factors (DE)
- The Hamner Institutes for Health Sciences (US)
- Goethe University Frankfurt (DE)
- Vrije Universiteit Brussel (BE)
- University of Freiburg (DE)
- Leipzig University (DE)
- Dow Chemical (United States) (US)
- Durham University (GB)
- Seoul National University (KR)
- Instituto de Investigación Sanitaria La Fe (ES)
- Heidelberg University (DE)
- University of Liverpool (GB)
- University of Groningen (NL)
- Lund University (SE)
- University of Manchester (GB)
- South Valley University (EG)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Regensburg (DE)
- Merck KGaA, Darmstadt (Germany) (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Musashino University (JP)
- University Hospital Zurich (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hewitt, Nicola J.
- ORCID
- Hewitt, Nicola J.
- Andersen, Melvin E.
- Bhattacharya, Sudin
- Bode, Johannes Georg
- Borner, Christoph
- Böttger, Jan
- Braeuning, Albert
- Budinsky, Robert A.
- Cameron, Neil R.
- Camussi, Giovanni
- Cho, Chong-Su
- Choi, Yun-Jaie
- Dahmen, Uta
- Damm, Georg
- Dirsch, Olaf
- Donato, María Teresa
- Dong, Jian
- Dooley, Steven
- Drasdo, Dirk
- Gibson, Andrew
- Glanemann, Matthias
- Groothuis, Geny M. M.
- Hallifax, David
- Hammad, Seddik
- Hayward, Adam
- Häussinger, Dieter
- Hellerbrand, Claus
- Hewitt, Philip
- Hoehme, Stefan
- Holzhütter, Hermann-Georg
- Houston, J. Brian
- Ito, Kiyomi
- Jaeschke, Hartmut
- Keitel, Verena
- Kordes, Claus
- Kullak-Ublick, Gerd A.
- LeCluyse, Edward L.
- Maltman, Daniel J.
- McMullen, Patrick
- Merfort, Irmgard
- Meyer, Christoph
- Mwinyi, Jessica
- Naisbitt, Dean J.
- Nussler, Andreas K.
- Olinga, Peter
- Pampaloni, Francesco
- Pi, Jingbo
- Pluta, Linda
- Przyborski, Stefan A.
- Ramachandran, Anup
- Rogiers, Vera
- Schwarz, Michael
- Singh, Bijay
- Stelzer, Ernst H. K.
- Stieger, Bruno
- Sugiyama, Yuichi
- Vanhaecke, Tamara
- Vinken, Mathieu
- Weiss, Thomas S.
- Woods, Courtney G.
- Hengstler, Jan G.
- Venue
- Archives of Toxicology
- Published
- 2013-08
- Volume
- 87
- Issue
- 8
- Pages
- 1315-1530
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC3753504
- OpenAlex
- W2134520937
- Cited by
- 1,280
- References
- 1,862
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 59 · 2023: 80 · 2022: 98 · 2021: 96 · 2020: 130 · 2019: 132 · 2018: 129 · 2017: 102 · 2016: 118 · 2015: 110 · 2014: 91 · 2013: 12
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Leibniz-Institut für Arbeitsforschung an der TU Dortmund
- Deutsche Forschungsgemeinschaft (GRK1104, (EXC 294))
- Agence Nationale de la Recherche
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Fonds Wetenschappelijk Onderzoek
- National Research Foundation of Korea
- Innoviris
- Universität Regensburg
- Vlaamse regering
- National Institutes of Health (AA12916)
- Biotechnology and Biological Sciences Research Council (1233823)
- Leibniz-Gemeinschaft
- Japan Society for the Promotion of Science (23590204)
- National Institute on Alcohol Abuse and Alcoholism (R56AA012916, R01AA012916)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK070195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- hepatotoxicity, primary hepatocytes, non-parenchymal liver cells, hepatocyte co-culture, precision-cut liver slices, isolated perfused liver, stem cell-derived hepatocytes, induced pluripotent stem cell-derived hepatocytes, nuclear receptors, Ras/MEK/ERK pathway, HNF4α, drug metabolism, ADME, drug interactions
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Liver, Inactivation, Metabolic, Organ Culture Techniques, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Toxicity Tests, Coculture Techniques, Hepatocytes, Toxicogenetics, Culture Techniques, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review